News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleGenetics Experts Support Adding Hundreds of Treatable Rare Diseases to Newborn Screening
May 9, 2023 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
A study found that 88% of experts surveyed on rare diseases agreed that DNA testing to reveal treatable genetic disorders should be available for all infants. This additional screening could allow lifesaving treatments to be delivered to babies sooner.
Artificial Intelligence Is Advancing Clinical Research and Data Quality
April 25, 2023 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Our Impact on Big Data
NCATS awardees use small business funding and CTSA Program grants to commercialize a customizable natural language processing software. The software captures and analyzes large amounts of data, facilitating improved clinical and biological research.
Better Method for Growing Stem Cells Could Speed Gene-Editing Therapies
April 7, 2023 - NCATS News
- Stem Cell Translation Laboratory (SCTL)
Scientists have published step-by-step instructions on how to use a four-part cocktail of drugs and compounds to grow stem cells from a single cell.
NIH Gene Therapy Team Reveals Its Path to FDA Orphan Drug and Rare Pediatric Disease Designations
March 29, 2023 - NCATS News
- Our Impact on Rare Diseases
- Our Impact on Research Operations
- Platform Vector Gene Therapy (PaVe-GT)
When NCATS received an Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA), it marked a key accomplishment for researchers in the NIH's Platform Vector Gene Therapy (PaVe-GT) project.
FDA-Approved Drug Shows Promise in Lab Models for Blinding Childhood Disease
March 29, 2023 - NCATS News
Strategy may speed delivery of therapeutic options relative to time it would take to develop gene therapies.
Tissue Chips in Space Projects Offer Glimpses Into the Biology of Aging
March 23, 2023 - NCATS News
- Tissue Chip for Drug Screening
The NCATS-led Tissue Chips in Space program sent its final projects to the International Space Station to learn about aging-related diseases and conditions and potentially translate results into treatments that help people on Earth.